Veradermics lands $256M IPO for oral Rogainenews2026-02-04T14:14:13+00:00February 4th, 2026|Endpoints News|
Carbon Health files for bankruptcy, seeking to sell or restructurenews2026-02-02T21:22:13+00:00February 2nd, 2026|Endpoints News|
Reed Jobs’ cancer biotech investment firm Yosemite eyes $350M fundnews2026-01-30T10:45:07+00:00January 30th, 2026|Endpoints News|
Agomab anticipates $182M IPO as it builds fibrosis pipelinenews2026-01-29T14:13:32+00:00January 29th, 2026|Endpoints News|
Flagship’s Repertoire gets another autoimmune partner in Lillynews2026-01-29T11:30:20+00:00January 29th, 2026|Endpoints News|
Tenpoint gets FDA nod for presbyopia eye drop and $235Mnews2026-01-29T06:08:04+00:00January 29th, 2026|Endpoints News|
Oral Rogaine maker Veradermics looks to raise $181M from IPOnews2026-01-28T19:18:51+00:00January 28th, 2026|Endpoints News|
Eikon seeks $273M IPO with pipeline led by Chinese cancer drugsnews2026-01-28T15:25:44+00:00January 28th, 2026|Endpoints News|
Included Health launches alternative health plannews2026-01-28T15:02:39+00:00January 28th, 2026|Endpoints News|
TRexBio gets another $50M to bring more Treg candidates into the clinicnews2026-01-27T12:00:48+00:00January 27th, 2026|Endpoints News|
